Meitheal Pharmaceuticals has gotten federal approval for a new kind of antibiotic for use on hospitalized patients with ...

Introduction By 2050, antimicrobial resistance (AMR) could lead to over 10 million deaths annually and $100 trillion in ...

Dangerous infections that no longer respond to antibiotics are spreading quickly around the world, increasing by as much as 15% a year.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It ...

The spread of antibiotic resistance, where infectious bacteria are able to defeat the drugs intended to kill them, may not be primarily driven by antibiotic consumption, according to a new study. The ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...